SERUM LEVELS OF THE ONCOFETAL ANTIGENS CA-125, CA-19-9 AND CA-15-3 IN PATIENTS WITH ENDOMETRIOSIS

被引：17
|
作者：
PANIDIS, D [1 ]
VLASSIS, G [1 ]
MATALLIOTAKIS, J [1 ]
SKIADOPOULOS, S [1 ]
KALOGEROPOULOS, A [1 ]
机构：
[1] ARISTOTELIAN UNIV SALONIKA, DEPT OBSTET & GYNECOL 3, SALONIKA, GREECE
来源：
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 1988年 / 11卷 / 11期
关键词：
D O I：
10.1007/BF03350229
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：801 / 804
页数：4
相关论文
共 50 条
  • [1] LEVELS OF THE TUMOR-MARKERS CA-125, CA-19-9, CA-15-3, CEA IN LHRH ANALOG THERAPY FOR ENDOMETRIOSIS
    CIRKEL, U
    OCHS, H
    SCHNEIDER, HPG
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) : 1022 - 1023
  • [2] DIAGNOSTIC-SIGNIFICANCE OF THE TUMOR-MARKERS CA-125, CA-19-9, CA-15-3 AND CEA IN ENDOMETRIOSIS
    CIRKEL, U
    OCHS, H
    LATUSSEK, B
    SCHNEIDER, HPG
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1991, 51 (08) : 626 - 631
  • [3] THE TUMOR-MARKERS CA-125, CA-19-9, CA-15-3 AND CEA IN OVARIAN-CANCER
    HOFFMANN, L
    MULLERHAGEN, S
    FRANZ, G
    KLAPDOR, R
    DIETEL, M
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 371 - 372
  • [4] SERUM CA-125 LEVELS IN PATIENTS WITH ENDOMETRIOSIS
    DORFFLER, P
    CAFFIER, H
    STECK, T
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) : 1017 - 1019
  • [5] SERUM CA-125 LEVELS IN PATIENTS WITH ENDOMETRIOSIS - CHANGES IN CA-125 LEVELS DURING MENSTRUATION
    MASAHASHI, T
    MATSUZAWA, K
    OHSAWA, M
    NARITA, O
    ASAI, T
    ISHIHARA, M
    OBSTETRICS AND GYNECOLOGY, 1988, 72 (03): : 328 - 331
  • [6] CA-19-9 AND CA-125 DETERMINATION BY IMMUNOLUMINOMETRIC ASSAY
    PLEBANI, M
    FAGGIAN, D
    MASIERO, M
    GIACOMINI, A
    BURLINA, A
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1990, 28 (12): : 919 - 921
  • [7] COMPARISON OF IMMUNOASSAYS FOR TUMOR-MARKERS CA-19-9, CA-15-3 AND CA-125 - DATA FROM AN INTERNATIONAL QUALITY ASSESSMENT SCHEME
    PILO, A
    ZUCCHELLI, GC
    COHEN, R
    BIZOLLON, CA
    CAPPELLI, G
    CIANETTI, A
    GION, M
    PIFFANELLI, A
    BOMBARDIERI, E
    TUMORI, 1995, 81 (02) : 117 - 124
  • [8] COMBINED USE OF CA-125 AND CA-15-3 IN PATIENTS WITH ENDOMETRIAL CARCINOMA
    SCAMBIA, G
    GADDUCCI, A
    PANICI, PB
    FOTI, E
    FERDEGHINI, M
    FERRANDINA, G
    AMOROSO, M
    CASTELLANI, C
    FACCHINI, V
    MANCUSO, S
    GYNECOLOGIC ONCOLOGY, 1994, 54 (03) : 292 - 297
  • [9] Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma
    Grankvist, K
    Ljungberg, B
    Rasmuson, T
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (02) : 233 - 236
  • [10] CA-125 AND CA-19-9 IN NON-HODGKINS-LYMPHOMA
    BUHL, C
    FULLBRANDT, U
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (23) : 921 - 922
12345